Michelson Diagnostics Founder Assumes Leadership Role
11 April 2016: Michelson Diagnostics today informed shareholders that Andy Hill has tendered his resignation from the position of CEO at Michelson Diagnostics Limited. Andy will step down from the role with immediate effect, but will continue to support the Company through a period of transition until the end of June.
Jon Holmes, founder and Chief Technology Officer, is assuming leadership of Michelson Diagnostics with immediate effect.
Jon and four colleagues founded Michelson Diagnostics in 2006 and under Jon’s leadership the Company has developed and proven VivoSight, a ground breaking, non-invasive imaging system for use in dermatology diagnosis and treatment monitoring.